New recommendations seek to reduce consumption of sugar, alcohol in U.S. diets
July 15, 2020 Dr. Beth Mayer-Davis is part of the Dietary Guidelines Advisory Committee, which has released new recommendations that aim to reduce the overconsumption of added sugars and alcohol in American diets.
Grant arms UNC-Chapel Hill with technology to accelerate COVID-19 research
July 15, 2020 The Chan Zuckerberg Initiative recently awarded a $433,000 grant to the University of North Carolina at Chapel Hill for laboratory equipment that will accelerate research to address the COVID-19 pandemic.
Leading maternal health advocacy groups tackle barriers to equitable maternity care for women and families of color
July 14, 2020 $4 million in Coronavirus Aid, Relief and Economic Security Act funding will support COVID-19 related telehealth access and infrastructure for maternal health services.
Gillings faculty urge World Health Organization to address potential airborne spread of COVID-19
July 14, 2020 Drs. Barbara Turpin, Glenn Morrison and Jason Surratt from the Department of Environmental Sciences and Engineering have joined more than two hundred scientists in signing an open letter to the World Health Organization expressing concern about the potential airborne spread of COVID-19.
‘She has a star in Chapel Hill’: Ethel Jean Jackson leaves indelible mark on public health education
July 13, 2020 The Gillings School celebrates the life of Ethel Jean Jackson, MPH, clinical assistant professor emerita and pioneer of the lay health advisor's role in health education. She leaves behind a legacy as a passionate advocate for community health outreach, particularly in communities of color.
Harvey Award will support mobile app for well-water testing
July 10, 2020 The Harvey Award recognizes exemplary faculty who reflect UNC's commitment to innovative engagement and outreach that addresses real-world challenges.
New study supports remdesivir as COVID-19 treatment
July 9, 2020 Researchers at the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center and Gilead Sciences report that remdesivir greatly inhibited SARS-CoV-2, the virus that causes COVID-19, in human lung cell cultures and also improved lung function in mice infected with the virus.
LaVange on front lines of effort to develop drugs for COVID-19
July 6, 2020 The National Institutes of Health have launched a public-private partnership to identify effective treatments for COVID-19. Dr. Lisa LaVange of the Gillings School is supporting two committees in the partnership.
Seven new Gillings Innovation Labs will tackle COVID-19
July 6, 2020 Exactly how does coronavirus spread in the air? What will get kids’ vaccinations back on track across the United States? How can public health practitioners work with church communities to spread accurate information about COVID-19? These are just three of the questions being explored by Gillings School researchers and their collaborators through a special COVID-19 round of Gillings Innovation Laboratory awards.
Groundbreaking study reveals genetic markers for Type 2 diabetes in East Asians
July 6, 2020 A recent study — the largest of its kind in any non-European population — demonstrates that while different populations of people share similar genetic predispositions for Type 2 diabetes, they also have some genetic variations that can alter their susceptibility to developing the disease.
